Case–control studies are particularly useful in investigating the association between exposure (DAPK promoter methylation) and outcome (NPC), as they provide a suitable framework for evaluating the diagnostic value of a biomarker. The gene discussed is DAPK1; the disease is nasopharyngeal carcinoma.